LeadStory

CNBC

Biotech takeover targets: Here’s what you need to know

CNBC · Current
CNBC
CNBC
Current

CNBC's Angelica Peebles reports the latest news surrounding Big Pharma.

Breakdown
  • Eli Lilly to acquire Syntessa Pharmaceuticals for up to $7.8 billion 11s
  • Syntessa develops orexin agonists for narcolepsy and neurological diseases 15s
  • Biogen acquires Apellis Pharmaceuticals for about $5.6 billion 1m 18s
  • Orexin agonist market could reach $15-20 billion annually 1m 3s
  • Biotech sector sees increased M&A activity with more companies to watch 1m 50s
Business